On 15 April 2013, the Supreme Court heard arguments to address the question, “Are human genes patentable?” and will deliver its ruling by the end of June. 

This will conclude a lawsuit that was filed on 12 May 2009, in the Federal District Court for Southern New York, Judge Robert Sweet presiding (1). 


The case centers on patents underlying genetic testing for inherited risk for breast and ovarian cancer attributable to 2 genes, BRCA1 and BRCA2